487 related articles for article (PubMed ID: 9578414)
1. Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.
Hartmann RR; Rimoldi D; Lejeune FJ; Carrel S
Melanoma Res; 1997 Aug; 7 Suppl 2():S27-33. PubMed ID: 9578414
[TBL] [Abstract][Full Text] [Related]
2. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition.
Stanwell C; Burke TR; Yuspa SH
Cancer Res; 1995 Nov; 55(21):4950-6. PubMed ID: 7585535
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
4. The adhesion of anti-CD3-activated mouse T cells to syngeneic colon adenocarcinoma cells is differentially regulated by protein tyrosine kinase-, protein kinase C-, and cAMP-dependent pathways in the effector cell.
MacKenzie WM; Hoskin DW; Blay J
Biochem Biophys Res Commun; 1999 Feb; 255(2):460-5. PubMed ID: 10049731
[TBL] [Abstract][Full Text] [Related]
5. Activation of mitogen activated protein kinase in human platelets by genistein.
Kansra SV; Reddy MA; Weng YI; Shukla SD
Pharmacol Res; 1999 Jan; 39(1):21-31. PubMed ID: 10051374
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
Hargreaves PG; Licking EF; Sargeant P; Sage SO; Barnes MJ; Farndale RW
Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
[TBL] [Abstract][Full Text] [Related]
7. Effects of genistein, a soybean-derived isoflavone, on proliferation and differentiation of B16-BL6 mouse melanoma cells.
Yan CH; Chen XG; Li Y; Han R
J Asian Nat Prod Res; 1999; 1(4):285-99. PubMed ID: 11523549
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53.
Rauth S; Kichina J; Green A
Br J Cancer; 1997; 75(11):1559-66. PubMed ID: 9184169
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of inorganic phosphate transport by insulin-like growth factor I and vanadate in opossum kidney cells is mediated by distinct protein tyrosine phosphorylation processes.
Palmer G; Bonjour JP; Caverzasio J
Endocrinology; 1996 Nov; 137(11):4699-705. PubMed ID: 8895336
[TBL] [Abstract][Full Text] [Related]
10. Early effects of protein kinase modulators on DNA synthesis in rat cerebral cortex.
Yakisich JS; Sidén A; Vargas VI; Eneroth P; Cruz M
Exp Neurol; 1999 Sep; 159(1):164-76. PubMed ID: 10486185
[TBL] [Abstract][Full Text] [Related]
11. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Ralph SJ; Wines BD; Payne MJ; Grubb D; Hatzinisiriou I; Linnane AW; Devenish RJ
J Immunol; 1995 Mar; 154(5):2248-56. PubMed ID: 7532663
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
[TBL] [Abstract][Full Text] [Related]
13. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
14. ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839).
Djerf EA; Trinks C; Abdiu A; Thunell LK; Hallbeck AL; Walz TM
Melanoma Res; 2009 Jun; 19(3):156-66. PubMed ID: 19434003
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
[TBL] [Abstract][Full Text] [Related]
16. PKC regulation of microfilament network organization in keratinocytes defined by a pharmacological study with PKC activators and inhibitors.
Masson-Gadais B; Salers P; Bongrand P; Lissitzky JC
Exp Cell Res; 1997 Oct; 236(1):238-47. PubMed ID: 9344604
[TBL] [Abstract][Full Text] [Related]
17. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
18. Myeloid differentiation associated tyrosine protein kinase activity in WEHI-3B murine monomyelocytic leukemia cells.
DiGiovanna MP; Sartorelli AC
Leukemia; 1991 Oct; 5(10):869-78. PubMed ID: 1720491
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
20. Specifying protein kinase C functions in melanoma.
Denning MF
Pigment Cell Melanoma Res; 2012 Jul; 25(4):466-76. PubMed ID: 22578192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
